OPTIMIZERX CORP (OPRX)
US68401U2042 - Common Stock
Notable Thursday Option Activity: MBI, RIVN, OPRX
Curious about what's happening in today's session? Check out the latest stock movements and price changes.
Which stocks are experiencing notable movement on Thursday?
Which stocks are moving on Thursday?
Let's have a look at the top gainers and losers in the middle of the day of today's session.
OptimizeRx Becomes Oversold (OPRX)
Thursday's session: gap up and gap down stocks
Let's have a look at what is happening on the US markets on Thursday. Below you can find the gap up and gap down stocks in today's session.
Curious about the stocks that are showing activity before the opening bell on Thursday?
As we await the opening of the US market on Thursday, let's delve into the pre-market session and discover the top gainers and losers shaping the early market sentiment.
Stay updated with the stocks that are on the move in today's after-hours session.
Top movers in Wednesday's after hours session
OptimizeRx Reports Third Quarter 2024 Financial Results
OptimizeRx Reports Third Quarter 2024 Financial Results
- Q3 revenue of $21.3 million, increasing 30% year-over-year - Q3 gross profit increased 37% year-over-year to $13.4 million with a gross margin of 63% -...
OptimizeRx Sets Third Quarter 2024 Conference Call for November 13, 2024 at 4:30 p.m. ET
OptimizeRx Sets Third Quarter 2024 Conference Call for November 13, 2024 at 4:30 p.m. ET
WALTHAM, Mass., Oct. 31, 2024 (GLOBE NEWSWIRE) -- OptimizeRx Corp. (the “Company”) (Nasdaq: OPRX), a leading provider of healthcare technology solutions...
Noteworthy Wednesday Option Activity: ADBE, CAR, OPRX
OptimizeRx Continues to Expand its Strategic Relationship with a Top-Tier Pharma Client via a Multi-Brand, Multi-Solution Investment Commitment with Over $10M In-Year Total Value
WALTHAM, Mass., Sept. 10, 2024 (GLOBE NEWSWIRE) -- OptimizeRx Corp. (the “Company”) (Nasdaq: OPRX), the leading provider of healthcare technology...
RSI Alert: OptimizeRx (OPRX) Now Oversold
OptimizeRx Launches Novel Brand Eligibility Technology, Enabling Dynamic Direct to Consumer Marketing for Healthcare Audiences
OptimizeRx Launches Novel Brand Eligibility Technology, Enabling Dynamic Direct to Consumer Marketing for Healthcare Audiences
The availability of Micro-Neighborhood® Targeting on the Company’s Dynamic Audience Activation Platform meets the demand of life sciences marketers by...
OPRX Stock Earnings: OptimizeRx Beats EPS, Misses Revenue for Q2 2024
OPRX stock results show that OptimizeRx beat analyst estimates for earnings per share but missed on revenue for the second quarter of 2024.
OPRX Stock Earnings: OptimizeRx Beats EPS, Misses Revenue for Q2 2024
InvestorPlace - Stock Market News, Stock Advice & Trading Tips OptimizeRx (NASDAQ:OPRX) just reported results for the second quarter of 2024.O...
OptimizeRx Reports Second Quarter 2024 Financial Results
OptimizeRx Sets Second Quarter 2024 Conference Call for August 8, 2024 at 4:30 p.m. ET
OptimizeRx Sets Second Quarter 2024 Conference Call for August 8, 2024 at 4:30 p.m. ET
WALTHAM, Mass., July 25, 2024 (GLOBE NEWSWIRE) -- OptimizeRx Corp. (the “Company”) (Nasdaq: OPRX), the leading provider of healthcare technology...
OptimizeRx Delivers AI-Guided Privacy-Compliant Platform for Pharmaceutical Brand Marketing Amid Evolving Consumer Privacy Legislation
OptimizeRx Micro Neighborhood® Targeting enables pharmaceutical brands to maintain and expand campaign scale nationwide
OptimizeRx Delivers AI-Guided Privacy-Compliant Platform for Pharmaceutical Brand Marketing Amid Evolving Consumer Privacy Legislation
OptimizeRx Micro Neighborhood® Targeting enables pharmaceutical brands to maintain and expand campaign scale nationwide...
OptimizeRx Demonstrates Measurable Script Lift for a Major Depressive Disorder Brand Targeting Physicians of Hard-to-Reach Patients
The Company’s AI-guided predictive targeting platform delivered three times the return in half the time of the traditional trigger-based program
OptimizeRx Demonstrates Measurable Script Lift for a Major Depressive Disorder Brand Targeting Physicians of Hard-to-Reach Patients
The Company’s AI-guided predictive targeting platform delivered three times the return in half the time of the traditional trigger-based program...
Notable Thursday Option Activity: SMCI, OPRX, TH
New White Paper Highlights How Closing the Health Information Gap Between Doctors and Patients Improves Life Science Marketing & Adds Value to Clinical Conversations
• 84% of Patients Arrive at Doctor Visits Underinformed• Underscores Growing Importance of HCP and DTC Alignment in Pharma Commercialization and Marketing...
OptimizeRx Breaks Below 200-Day Moving Average - Notable for OPRX
OPRX Stock Earnings: OptimizeRx Beats EPS, Beats Revenue for Q1 2024
OPRX stock results show that OptimizeRx beat analyst estimates for earnings per share and beat on revenue for the first quarter of 2024.
OPRX Stock Earnings: OptimizeRx Beats EPS, Beats Revenue for Q1 2024
InvestorPlace - Stock Market News, Stock Advice & Trading Tips OptimizeRx (NASDAQ:OPRX) just reported results for the first quarter of 2024.Op...
OptimizeRx Reports First Quarter 2024 Financial Results
Q1 revenue of $19.7 million, increasing 51% year-over-yearQ1 gross profit increased 64% year-over-year to $12.2 million with a gross margin of 62%Won 9...